RefleXion Medical’s SCINTIX biology-guided radiotherapy platform (BgRT) has shined in an observational study involving lung and bone cancer patients. During the US-based PREMIER trial (NCT05406167), ...

HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson ...

Targeted radiotherapy company RefleXion Medical has raised $80 million to help broaden its cancer offerings after recently exploring the company’s potential in treating prostate cancer and other ...

RefleXion Medical is all-in on its biology-guided radiotherapy (BgRT) system—so much so, in fact, that the startup has more than doubled its existing debt to prepare for the technology’s commercial ...

HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, Inc., a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality that will one day treat all stages of cancer, ...

"The PREMIER Registry findings mark a milestone for our field," said Sean Shirvani, M.D., MPH, chief medical officer at RefleXion. "We are beginning to see the clinical translation of a technology ...

What if you could take cancer’s natural activity in the human body and turn it back on itself? That’s the premise behind RefleXion, which made its debut at last week’s ASTRO Annual Meeting with a ...